Release Date: 13/11/12 14:39 Summary: Appendix 3B Issue of PSRs and Options Price Sensitive: No Download Document 105.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%